Healthcare >> CEO Interviews >> October 12, 2001
STEVEN M. RAUSCHER is President and Chief Executive Officer of Oscient
Pharmaceuticals Corporation. He has been a director since 1993 and
joined the company full-time as President and Chief Executive Officer in
2000. Before joining Oscient Pharmaceuticals, Mr. Rauscher spent 18
years at Abbott Laboratories, serving in a variety of key leadership
positions including Vice President for Corporate Licensing; Vice
President of Business Development; Vice President of Sales U.S.
Pharmaceutical Products Division; Director of Strategic Planning for
Pharmaceutical Products; and General Manager, Abbott West Indies.
Following his time at Abbott, Mr. Rauscher served as CEO of
AmericasDoctor, a company that provides clinical research and marketing
services to the pharmaceutical industry. Mr. Rauscher holds an MBA from
the University of Chicago. Profile
of the company.
Mr. Rauscher: Genome Therapeutics is a genomic-based biopharmaceutical
company. The company operates two
